Dyclonine (hydro<wbr/>chloride)

Dyclonine (hydrochloride)

CAT N°: 27667
Price:

From 92.00 78.20

Dyclonine is a topical anesthetic that also has antimicrobial, anticancer, and neuroprotective properties.{52157,52158,52159} It is active against S. aureus, B. subtilis, E. coli, P. vulgaris, P. aeruginosa, C. albicans, M. lanosum, and T. mentagrophytes with minimum microbicidal concentrations (MMCs) ranging from 0.006 to 0.8% v/v.{52157} Dyclonine (25-100 ?M) reduces aldehyde dehydrogenase (ALDH) activity in and viability of HSC-4 oral squamous cell carcinoma cells and enhances HSC-4 and OSC19 cell death induced by sulfasalazine (Item No. 15025).{52158} In vivo, dyclonine (5 mg/kg per day) reduces tumor volume in an HSC-2 mouse xenograft model when administered alone or in combination with sulfasalazine. Dyclonine also induces cerebral frataxin (FXN) production and decreases time to cross and the number of foot slips in a level beam test in a mouse model of Friedreich’s ataxia.{52159}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 1-(4-butoxyphenyl)-3-(1-piperidinyl)-1-propanone, monohydrochloride
  • Correlated keywords
    • 586-60-7 anti microbial cancer neuro protective Staphylococcus Hay Bacillus Escherichia Proteus Pseudomonas Candida Microsporum Trichophyton micro bicidal HSC4 OSC-19 HSC2 OSC-19 Diclonina Dyclocaine
  • Product Overview:
    Dyclonine is a topical anesthetic that also has antimicrobial, anticancer, and neuroprotective properties.{52157,52158,52159} It is active against S. aureus, B. subtilis, E. coli, P. vulgaris, P. aeruginosa, C. albicans, M. lanosum, and T. mentagrophytes with minimum microbicidal concentrations (MMCs) ranging from 0.006 to 0.8% v/v.{52157} Dyclonine (25-100 ?M) reduces aldehyde dehydrogenase (ALDH) activity in and viability of HSC-4 oral squamous cell carcinoma cells and enhances HSC-4 and OSC19 cell death induced by sulfasalazine (Item No. 15025).{52158} In vivo, dyclonine (5 mg/kg per day) reduces tumor volume in an HSC-2 mouse xenograft model when administered alone or in combination with sulfasalazine. Dyclonine also induces cerebral frataxin (FXN) production and decreases time to cross and the number of foot slips in a level beam test in a mouse model of Friedreich’s ataxia.{52159}

We also advise you